## Abstract Patients who receive curative treatment for lung cancer can develop additional lung tumors that may or may not be related to the original tumor and thus require different clinical management. If a subsequent tumor has a pattern of allele loss, revealed by allelotype analysis, overlappin
Allelic losses in human chromosome II in lung cancers
โ Scribed by Masayoshi Lizuka; Yuki Sugiyama; Masahiko Shiraishi; Carol Jones; Dr. Takao Sekiya
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 524 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
โฆ Synopsis
The relatively frequent loss of heterozygosity at loci on the short arm of chromosome I I in human lung cancers has suggested the presence of a putative tumor suppressor gene. For location of the gene, a fine deletion map of human chromosome I I was constructed by analysis of DNAs from 79 lung cancers with 3 I sequence-tagged-site markers that dotted chromosome I I and detected polymorphic changes in nucleotide sequences. The results showed that three regions, I I p 12-p IS, I I q 12, and I I q I4-q24, were commonly deleted in a considerable number of cancers, indicating the possible presence of more than one tumor suppressor gene. The range of deletion in the I I p I 5 region was estimated to be 4.5 megabases. That in the I I q24-q24 region was divided into two portions: one was 3 cM in length, and the other was longer and could not be specified because of lack of appropriate markers. The deletion in the I I q I 2 region was so short that two markers flanking the region could not be identified by genetic analysis. Genes Chrornosorn Cancer 13:40-46 (1995).
๐ SIMILAR VOLUMES
We have previously reported a complete allelotype study of 86 primary breast carcinomas, in which each non-acrocentric chromosome arm was studied with at least one polymorphic DNA-marker for the presence of allelic imbalance (Al, allelic loss or allelic gain) in the tumor. Here we report the statist
Forty-eight samples of primary non-small-cell lung cancer (NSCLC) and normal tissue from the same patients were analyzed for allelic deletions on chromosome I I p. Five polymorphic loci were assessed to determine the incidence of I Ip sequence deletions and to define hot-spots of deletions. Informat
Molecular genetic analyses of human prostate cancer (CaP) has revealed frequent loss of specific chromosome regions suggesting the presence of putative tumor suppressor gene(s) (TSG) on these chromosome loci whose inactivation may play a role in prostate tumorigenesis. To understand the role of 6q a
Acoustic neuromas occur either as sporadic solitary tumors in the general population or as inherited bilateral tumors typically in patients with neurofibromatosis type 2. Loss of heterozygosity for markers on the long arm of chromosome 22 has been reported in both instances, and neurofibromatosis ty
The prognostic significance of chromosome 18q allelic loss was evaluated in a series of 118 patients with curatively resected TNM stage II or stage III colon cancer. Chromosome 18q status was determined on frozen tumour samples, using microsatellite markers and the polymerase chain reaction (PCR). M